Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assays

By Vessella R.L.   Lange P.H.   Partin A.W.   Chan D.W.   Sokoll L.J.   Sasse E.A.   Crawford E.D.  

Urology, Vol. 55, Iss. 6, 2000-06 ,pp. : 909-914

Elsevier

Access to resources Recommend Favorite

Age-specific serum levels of complexed PSA (CPSA) for prostate cancer screening

By Bartsch G.   Cheli C.   Levine R.   Klocker H.   Horninger W.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 186-186

Elsevier

Access to resources Recommend Favorite

Postneoadjuvant hormone PSA levels and prognosis in locally advanced prostate cancer

By Velasco J.   Tekyi-Mensah S.   Bolton S.   Forman J.D.  

Urology, Vol. 54, Iss. 2, 1999-08 ,pp. : 325-328

Elsevier

Access to resources Recommend Favorite

Power Doppler ultrasonography-directed prostate biopsy in men with elevated serum PSA levels: an evaluation of the clinical utility and limitations

By Takahashi S.   Yamada Y.   Homma Y.   Horie S.   Hosaka Y.   Kitamura T.  

Urology, Vol. 60, Iss. 2, 2002-08 ,pp. : 248-252

Elsevier

Access to resources Recommend Favorite

PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml

By Fang J.   Metter E.J.   Landis P.   Carter H.B.  

Urology, Vol. 59, Iss. 6, 2002-06 ,pp. : 889-893

Elsevier

Access to resources Recommend Favorite